Introduction
The currently understood biology of LRRK2 suggests that studies of this protein may provide new insights into neurodegeneration that are broadly relevant to sporadic PD and amenable to therapeutic targeting. Genome-wide association studies demonstrate that common variation around the locus that encodes LRRK2 segregates with increased risk for PD (1, 2) , and missense mutations in LRRK2 cause a clinical and neuropathological syndrome that is indistinguishable from typical-appearing sporadic PD (3) . LRRK2 contains GTPase and kinase domains, as well as leucine-rich repeat (LRR) and WD40 protein-protein interaction domains ( Figure 1A ). Many potentially pathogenic sequence alterations have been identified in LRRK2, but only five missense mutations ( Figure 1A ) clearly segregate with PD in large family studies (4) . Two of these mutations (R1441G, R1441C) are located in the GTPase domain (termed Ras of complex proteins, or "Roc" domain), a third (Y1699C) falls in a region between the GTPase and kinase domains (termed the C-terminal of Roc, or "COR" domain), and two other mutations (G2019S and I2020T) are in the kinase domain.
LRRK2 appears to exist as a dimer (5) (6) (7) , and studies of fragments of LRRK2 or its prokaryotic homolog indicate dimerization occurs in the Roc-COR region (5) . Structural analyses of these fragments indicate that the R1441C PD mutation (or mutation of the analogous residue in the prokaryotic protein) can destabilize the dimer formed by these fragments (5, 8 ). Yet, available data do not define the functional significance of LRRK2 selfassociation and it is unclear whether this property is altered in PD mutant forms of the fulllength protein. One possibility is that LRRK2 self-association regulates its kinase activity, but only the G2019S mutation clearly increases kinase activity (by ~3-5 fold), whereas the other mutations appear to have little or no effect on kinase function (9) (10) (11) (12) (13) , at least in the in vitro by guest on http://hmg.oxfordjournals.org/ Downloaded from 5 assays used thus far. Intact kinase function does appear necessary for LRRK2 toxicity in vitro and in vivo (9, 12, 14) . LRRK2-induced neurodegeneration of primary neuronal cultures is caspase-dependent, and may involve activation of the FADD-caspase-8 pathway (15) . One site of LRRK2 toxicity may be in neuronal processes, as overexpression of LRRK2 in vitro or in vivo causes neurite shortening whereas loss of LRRK2 function leads to increased neuron length and branching (11) . The molecular details that underlie LRRK2 effects in neuronal processes are not clear, but may involve interactions with the cytoskeleton or cytoskeletalrelated molecules (10, (16) (17) (18) .
Here, we provide evidence that four PD mutations (R1441C, R1441G, Y1699C, I2020T) cause LRRK2 to decorate microtubules in a well-ordered periodic fashion, as evidenced by immunofluorescence, immuno-electron microscopy (EM) and EM tomographic studies.
Microtubule-associated LRRK2 appears as filamentous structures in transfected cell lines or primary neuronal cultures and the frequency of these structures increases with microtubule stabilization (taxol) and decreases with microtubule dissolution (nocodazole). Similar to LRRK2-induced neurodegeneration, filament formation requires intact kinase function and the WD40 domain, potentially linking LRRK2 microtubule association to neurodegeneration. Our observations identify a novel effect of LRRK2 PD mutations, and provide a platform to further dissect LRRK2-related signals by identifying factors that modulate the interaction between LRRK2 and microtubules.
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Results
LRRK2 PD Mutations Enhance LRRK2 Filament Formation
In multiple cell lines (including CAD, HEK and HeLa) transfected with wild type LRRK2 we observed that LRRK2 adopted a primarily diffuse cytosolic distribution, but we also observed LRRK2-positive aggregates and a distinct pattern of filament formation ( Figure 1B ). These patterns were observed with different epitope tags (e.g., GFP and V5) as well as with untagged protein (data not shown). To determine whether PD mutations alter the subcellular distribution of LRRK2, we quantified the frequency of these patterns (diffuse, aggregate or filament) for WT and all PD mutant alleles ( Figure 1C and E). This analysis was performed in the neuronal catecholaminergic CAD cell line because of the robust transfection efficiency possible with this system. The percentage of cells with punctate aggregates was not increased by any of the PD mutant alleles ( Figure 1C ), so these structures may represent a non-specific effect of LRRK2 overexpression. In contrast, filament formation was significantly enhanced by all LRRK2 PD mutations that do not consistently enhance kinase function (9, 10, 13), whereas no effect on filament formation was observed for the single mutant, G2019S, that consistently and significantly increases kinase activity (Figure 1D and E; Supplemental Figure   1 ; 9, 10, 13). Notably, steady state protein levels of WT and PD mutant LRRK2 are similar (data not shown), so these filament-forming mutations do not appear to act by altering LRRK2 stability. Morphologically, these filaments are reminiscent of death-effector filaments (DEFs) formed by FADD, caspase-8, TRADD and BCL10 (19) (20) (21) . This observation intrigued us because all of these filament-forming proteins participate in cell death-related signaling, potentially providing a clue to LRRK2 function relevant to neurodegeneration. We found that 7 LRRK2 filaments also occur in LRRK2-transfected primary neurons, both in the cell body and in neurites, and with both YFP-tagged as well as untagged protein ( Figure 1F ).
For previously characterized filament-forming proteins, filament formation reflects a homotypic protein-protein interaction that is required for their normal signaling function (19, 20, 22) . Oligomerization is also a signaling mechanism employed by RIP1 and RIP2 kinases (23) , close phylogenetic relatives of LRRK2. These facts led us to hypothesize that the filaments represent enhanced LRRK2 oligomerization. To investigate whether LRRK2 oligomerizes, we co-expressed GFP-and V5-LRRK2 in CAD cells and tested whether they coimmunoprecipitate (co-IP). Lysates were immunoprecipitated with a GFP antibody and probed for associated V5-LRRK2. Differentially tagged WT-LRRK2 molecules did co-purify, indicating that LRRK2 can oligomerize ( Figure 1G ). Moreover, LRRK2 oligomerization was clearly enhanced by filament-forming PD mutations (R1441C, Y1699C, I2020T), whereas the nonfilament-inducing mutant (G2019S) did not differ from the WT-LRRK2 control ( Figure 1G ). The oligomerization status of LRRK2 mutants therefore correlates with the level of filament formation, indicating that the cytosolic filaments are related to this feature of LRRK2 biology.
Because the LRRK2 filaments appear similar to cytoskeletal structures, we explored whether LRRK2 was templating onto existing cytoskeletal elements or forming novel "LRRK2 only" structures. To determine which, if any, cytoskeletal structures LRRK2 may interact with, we examined cells transfected with FLAG-LRRK2-I2020T with both anti-FLAG and a panel of antibodies against the major cytoskeletal elements, as well as with mito-tracker, since mitochondria exist in filamentous strands. However, LRRK2 filament staining did not colocalize with any of these markers (data not shown). 
LRRK2 Decorates Microtubules In An Organized Manner
To further explore the nature of LRRK2 filaments we employed electron microscopy to define the ultrastructure of these structures. We performed correlated light and electron microscopy (EM) by transfecting HEK293T cells with YFP-LRRK2-I2020T, using YFP fluorescence to identify filament-bearing cells, and then processed the same samples for EM to obtain high-resolution information on LRRK2 distribution in specific subcellular domains. Figure 2G ) interrupted by bundles of microtubules decorated by electron densities around them (indicated by black arrowheads in Figure 2G ). Immuno-EM using a specific antibody to LRRK2 confirmed the specificity of LRRK2 densities around the microtubules ( Figure 3A ). To further examine the 3D electron microscopic organization of the filaments, we performed electron tomography on 250 nm thick sections. The tomograms show that LRRK2 appears to interact closely with the microtubules in a well-ordered, periodic fashion This distinction between the behavior of the G2019S and the other PD mutations is similar to that observed for their kinase activity (Supplemental Figure 1 ; 9-13). Taken together with the observations of LRRK2 coating microtubules by EM tomography, these data further indicate that multiple LRRK2 PD mutations (but not G2019S) enhance its ability to associate with microtubules. As cellular stressors, it is possible that taxol and nocodazole treatment alter LRRK2 behavior through indirect mechanisms, though the fact that they modulate filament formation in opposite directions makes this unlikely.
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LRRK2 Microtubule Association Requires Intact Kinase Function and the WD40 Domain
Because intact kinase activity is required for the enhanced neurotoxicity of LRRK2 PD mutants (9, 12; Supplemental Figure 1 ), we tested whether this activity was also required for the enhanced microtubule association caused by LRRK2 PD mutations. Consistent with the neurotoxicity data, blocking kinase activity by introducing a second mutation in the kinase domain, K1906R, completely abolished the effect of LRRK2 PD mutations on microtubule association ( Figure 5A ). To further elucidate the mechanism whereby LRRK2 PD mutations provoke enhanced microtubule association, we attempted to define a microtubule association domain by performing a structure-function study, testing which regions of LRRK2 are required (or are dispensable) for filament formation. We used the I2020T mutant as a representative mutation for these studies since the behavior of this mutant does not differ from R1441C or Y1699C (see Figures 1 and 4 ). This analysis demonstrated that the WD40 domain was necessary for filament formation ( Figure 5B ), whereas the entire N-terminus (prior to the LRR domain) is dispensable for microtubule binding. We reported previously (7) that WD40-LRRK2 is unable to autophosphorylate yet retains the ability to trans-phosphorylate the model substrate MBP, suggesting a potential relationship between autophosphorylation and microtubule association. Such a relationship could contribute to an explanation of why blocking kinase function virtually abolishes microtubule association ( Figure 5A ).
Discussion
Our study is the first to provide evidence that multiple PD mutations enhance the association of LRRK2 with microtubules. Several characteristics of this interaction indicate that it may contribute to LRRK2-dependent neurodegeneration. First, similar to LRRK2 neurotoxicity, this effect requires intact LRRK2 kinase function and the presence of the WD40 domain (7, 9, 12, 14) . Second, our colocalization and ultrastructural analyses show that contrast, we used a validated LRRK2 antibody for detection (as well as an epitope tag), and employed correlated light and electron microscopy to ensure that we were observing the ultrastructural features of the same structures we visualized using immunofluorescence. We never observed membrane in association with LRRK2 filaments, either by EM or using membrane dyes on LRRK2 transfected cells (data not shown). One potential mechanism for the enhanced microtubule association of mutant LRRK2 is that PD mutations may directly enhance the affinity of LRRK2 for microtubules or microtubule-bound proteins.
Alternatively, PD mutations may enhance LRRK2 homo-oligomerization or complex formation with other cytosolic proteins, and these homo-oligomers or protein complexes may themselves have enhanced affinity for microtubules. Our data provide evidence that multiple pathogenic mutations enhance LRRK2-LRRK2 interactions, an effect that requires intact kinase activity and that is correlated with filament formation. Studies from Wittinghofer and colleagues suggest that the COR domain is important for LRRK2 dimerization (8) , and data from Cookson and colleagues (5) 
Materials and Methods
Plasmids. LRRK2 cDNA from HEK 293 cells was cloned in pCMS-EGFP (Clontech), pcDNA-DEST53 and -DEST40 (Invitrogen). All subsequent mutants were generated using site directed mutagenesis and all mutant clones were re-sequenced to confirm their accuracy. The rabbit anti-LRRK2 used to immunostain untagged LRRK2 was a kind gift from Dr. Benoit
Cell
Giasson (University of Pennsylvania, Philadelphia, PA).
Cell preparation for electron microscopy. HEK293T cells transfected with YFP-LRRK2-IT
were fixed for 30 minutes in 2% glutaraldehyde in 0.1M sodium cacodylate buffer (pH 7.4) on ice. After washes in 0.1M cacodylate buffer, cells were postfixed with 1% osmium tetraoxide for 30 minutes, stained with 2% uranyl acetate, and then dehydrated and embedded in Durcupan epoxy resin. Sections were cut using a diamond knife at a thickness of 70-90 nm for thin sections and 250 nm for thick sections. Post-staining of grids was done with 2% uranyl acetate for 5 minutes and lead citrate for 1 minute. Thin sections were examined using a JEOL 1200 FX1 operated at 120 KV.
Electron tomography. Colloidal gold particles (10 nm diameter) were deposited on opposite sides of the thick epoxy sections to serve as fiducial markers. For stability in the beam, the section was coated with carbon on both sides. For reconstruction, a triple series of images at regular tilt (angular increments of 2° from -60° to +60° increments) was collected with a JEOL 4000EX intermediate-voltage electron microscope operated at 400 kV. The specimens were irradiated before initiating a tilt series to limit anisotropic specimen thinning during image collection. Tilt series were recorded using a slow-scan CCD camera. The pixel dimensions of the CCD camera were 4K x 4K and the pixel resolution was 0.754 nm. Fine alignment and reconstruction was performed using the TxBR software package (33) .
Post-embedding immuno-EM.
For ultrastructural analysis of the filaments we used an anti-LRRK2 antibody using 10 nm gold particles to identify the LRRK2 protein around the microtubules. After labeling, grids were washed and post stained with 2% uranyl acetate for 5 minutes and lead citrate for 1 minute. shown as a relative ratio of co-purified V5-LRRK2 to GFP-LRRK2, normalized to the WT-LRRK2 ratio. 
